(Q37859779)

24 August 2017

title

Wrongfully accused: metformin use in heart failure (English)

1 reference

24 August 2017

0 references

1 reference

Dean T Eurich

1

1 reference

24 August 2017

Finlay A McAlister

series ordinal

2

1 reference

24 August 2017

publication date

1 February 2011

1 reference

Expert Review of Cardiovascular Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

9

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

147-150

1 reference

Heart failure: the frequent, forgotten, and often fatal complication of diabetes

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Incidence of lactic acidosis in metformin users

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Metformin use and mortality among patients with diabetes and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.186

21 January 2018

Identifiers

DOI

10.1586/ERC.10.186

1 reference

24 August 2017

1 reference